Article
Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Feb 2017
Inaguma Shingo, Lasota Jerzy, Wang Zengfeng, Felisiak-Golabek Anna, Ikeda Hiroshi, Miettinen Markku
Abstract excerpt
The CD274 (PD-L1)/PDCD1 (PD-1) pathway is crucial for the modulation of immune responses and self-tolerance. Aberrantly expressed CD274 allows tumor cells to evade host immune system and is considered to be a mechanism of adaptive immune resistance. Inhibition of the CD274/PDCD1 immune checkpoint offers a promising new therapeutic strategy. Although CD274-expressing tumor cells have been identified in different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
